https://www.cnbc.com/2024/04/30/ftc-challenges-patents-held-by-drugmakers-including-for-ozempic.html https://www.cnbc.com/2024/04/30/ftc-challenges-patents-held

https://www.cnbc.com/2024/04/30/ftc-challenges-patents-held-by-drugmakers-including-for-ozempic.html https://www.cnbc.com/2024/04/30/ftc-challenges-patents-held-... My understanding is that they are patentening the drug+device and or the dosing, not the molecule. Looks like the FTC is clamping down on it.